What is the Flexible and Semi-Rigid Ureteroscopy Market Size in 2026?
The global flexible and semi-rigid ureteroscopy market size accounted for USD 1.50 billion in 2025 and is predicted to increase from USD 1.61 billion in 2026 to approximately USD 3.09 billion by 2035, expanding at a CAGR of 7.50% from 2026 to 2035.The market is driven by the rising incidence of urologic conditions and ongoing advancements in healthcare technologies.
Key Takeaways
- North America led the flexible and semi-rigid ureteroscopy market in 2025 with a 35% share.
- The Asia Pacific is expected to grow at the fastest CAGR of 9% between 2026 and 2035.
- By product type, the flexible ureteroscopes segment led the market with a 60% shar in 2025.
- By product type, the semi-rigid ureteroscope segment is expected to expand at the fastest CAGR of about 8% in the upcoming period.
- By application, the kidney stones treatment segment led the global market in 2025 while holding a 50% share.
- By application, the UTI treatment segment is the second-largest shareholder and is expected to grow at a 6.5% CAGR over the forecast period.
- By end-use, the hospitals segment led the global market with a 60% share in 2025.
- By end-use, the ambulatory surgery centers (ASCs) segment is expected to grow at the fastest CAGR of 8.5% during the projection period.
Flexible and Semi-Rigid Ureteroscopy Market Overview
Flexible and semi-rigid ureteroscopy are key techniques that have gained immense popularity for their strong efficacy and safety profiles. Flexible ureteroscopy allows the deflection of complex or hard-to-reach stones, as it can access the proximal ureter and intrarenal areas. Semirigid ureteroscopy, the most widely used method for ureteral lithiasis worldwide, is effective for stones accessible without complex deflection and offers shorter operative times, lower costs, and excellent outcomes with minimal complications. The choice of technique ultimately depends on the surgeon's preference, available equipment, and cost considerations.
Impact of Artificial Intelligence on the Flexible and Semi-Rigid Ureteroscopy Market
Artificial intelligence is increasingly shaping the landscape of the flexible and semi-rigid ureteroscopy market, extending applications from diagnostic imaging to intraââ¬âoperative guidance and endoscopic skill assessment. Deep learning models can automatically segment and measure urinary stones on CT, helping clinicians choose candidates, scope type, and access strategy with nearââ¬âperfect detection accuracy. AI tools enhance intraââ¬âoperative visualization, improve patient safety, raise stoneââ¬âfree rates, and support better outcomes by quantitatively tracking stone fragments and residual burden in real time. Adaptable, dataââ¬âdriven algorithms can also guide periââ¬âprocedural antibiotic selection for ureteroscopic management of UTIs, reducing complications and resistance. Overall, AI streamlines physicians' workflows and improves efficiency across the entire ureteroscopy care pathway.
Flexible and Semi-Rigid Ureteroscopy Market Trends
- Technological Advancements: Technological advances in ureteroscopy devices drive the market. Modern ureteroscopes feature enhanced imaging, reduced diameter, and improved flexibility, enabling more precise and efficient surgical procedures , driving adoption across healthcare settings.
- Integration of Digital Imaging and Enhanced Mobility: Increasing integration of digital cameras and improved range of motion in flexible ureteroscopes enhances visualization and manoeuvrability, supporting better diagnosis and treatment outcomes.
- Rising Preference for Semi-Rigid Ureteroscopes: Semi-rigid ureteroscopes provide a balance between stability and adaptability, enabling better navigation through anatomical curves, though slightly compromising visualization clarity compared to rigid devices.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 1.50 Billion |
| Market Size in 2026 | USD 1.61 Billion |
| Market Size by 2035 | USD 3.09 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 7.50% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Product Type, Application, End-Use, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Market Dynamics
Drivers
Expanding Healthcare Infrastructure and Aging Population
Improved healthcare access and a growing elderly patient base are significantly accelerating the adoption of ureteroscopy techniques. The expansion of healthcare infrastructure is increasing access to advanced urological procedures, enabling more hospitals and specialty clinics to adopt flexible and semi-rigid ureteroscopy for effective stone management. At the same time, the aging population is more prone to urinary tract conditions such as kidney stones, driving higher demand for minimally invasive treatment options.
Restraint
High Cost and Technical Limitation
High costs associated with advanced ureteroscopy equipment, maintenance, and procedures may limit adoption, particularly in smaller healthcare facilities and cost-sensitive regions. In addition, technical limitations such as the need for skilled specialists, complex handling of flexible scopes, and risk of equipment damage limit widespread usage, thereby restraining the market growth.
Opportunity
Advancements in AI and Visualization Technologies
Ongoing advancements in AI-driven diagnostics and enhanced visualization techniques are creating opportunities in the flexible and semi-rigid ureteroscopy market. These advances enable predictive analysis, improving procedural accuracy and facilitating innovation in ureteroscopy devices.
Segment Insights
Product Type Insights
Flexible and Semi-Rigid Ureteroscopy Market Share, By Product Type , 2025-2035 (%)
| Product Type | 2025 | 2035 | CAGR (%) |
| Flexible Ureteroscopes | 60.00% | 58.00% | 7.0% |
| Semi-Rigid Ureteroscopes | 40.00% | 42.00% | 8.0% |
The Flexible Ureteroscopes Segment Dominated the Market With a 60% Share in 2025
In 2025, the flexible ureteroscopes segment dominated the flexible and semi-rigid ureteroscopy market with around 60% share. This is mainly due to their enhanced manoeuvrability, visualization, and patient comfort during procedures. They offer exceptional flexibility and durability through passive bending technology, which safeguards the device from damage while facilitating access to previously inaccessible regions of the kidney. Contemporary flexible ureteroscopes generally feature an 8F tip diameter and can reach the upper urinary tract without necessitating intramural dilation or causing trauma. These characteristics significantly contribute to their increasing adoption.
The semi-rigid ureteroscopes segment held a 40% share of the market in 2025 and is projected to grow at the fastest CAGR of 8% during the forecast period. This growth is attributed to the ongoing preference for semi-rigid ureteroscopes, which are valued for their durability and ability to access challenging anatomical areas with ease. Furthermore, they provide a more cost-effective reprocessing option, while features such as a self-dilating insertion tube and atraumatic tip design facilitate smoother insertion into narrow ureters. Collectively, these advantages are expected to drive their adoption.
Application Insights
Flexible and Semi-Rigid Ureteroscopy Market Share, By Application , 2025-2035 (%)
| Application | 2025 | 2035 | CAGR (%) |
| Kidney Stones Treatment | 50.00% | 48.00% | 7.8% |
| Urinary Tract Infections (UTI) Treatment | 20.00% | 18.00% | 6.5% |
| BladderTumorsTreatment | 15.00% | 16.00% | 7.2% |
| Others | 15.00% | 18.00% | 9.0% |
The Kidney Stones Treatment Segment Dominated the Market in 2025
The kidney stones treatment segment dominated the flexible and semi-rigid ureteroscopy market with approximately 50% share in 2025. This is mainly due to the rising prevalence of kidney stones and the development of minimally invasive procedures. Moreover, ureteroscopy can treat stones located at any position in the ureter and kidney, including those that are not visible on X-ray imaging. This broad therapeutic capability is a key factor supporting the segment's market dominance.
The bladder tumors treatment segment held a 15% market share in 2025 and is expected to grow at a CAGR of 7.2% during the projection period. This growth is driven by the rising incidence of bladder cancer and the proven effectiveness of ureteroscopy for tumor resection. When combined with renal surgery and laparoscopy, ureteroscopy enables histologic diagnosis of filling defects in the upper urinary tract, facilitates the removal of small to large intraluminal lesions, and supports comprehensive tumor management.
The urinary tract infections (UTI) treatment segment was the second-largest shareholder in 2025, holding about 20% share, and is expected to grow at a CAGR of approximately 6.5% in the upcoming period. The growth of this segment is primarily driven by the rising incidence of UTIs, particularly in women, which is increasing the adoption of flexible and semi-rigid ureteroscopy for both diagnostic and therapeutic purposes. Ureteroscopy procedures allow detailed examination of tissues and structures in the urinary tract, especially in cases of recurrent infections, thereby supporting broader market adoption.
End-Use Insights
Hospitals Led the Market With a Major Share of 60% in 2025
The hospitals segment led the flexible and semi-rigid ureteroscopy market with a 60% share in 2025, driven by the increasing number of urological surgeries and specialized treatment needs. Hospitals offer multidisciplinary care, access to the latest instruments, and collaboration among specialists such as physicians and radiologists. In addition, hospitals provide adequate staffing, comprehensive post-operative care, and supporting services such as food pantries and nursing facilities, making them the preferred setting for surgical procedures.
Flexible and Semi-Rigid Ureteroscopy Market Share, By End-Use, 2025-2035 (%)
| End-Use | 2025 | 2035 | CAGR (%) |
| Hospitals | 60.00% | 58.00% | 7.0% |
| Specialized Urology Clinics | 25.00% | 26.00% | 8.0% |
| Ambulatory SurgeryCenters(ASCs) | 10.00% | 11.00% | 8.5% |
| Others | 5.00% | 5.00% | 6.5% |
The ambulatory surgery centers (ASCs) segment held a 10% share of the market in 2025 and is expected to expand at the fastest CAGR of 8.5% over the forecast period. This is primarily due to the rising trend of outpatient surgeries and minimally invasive procedures. ASCs are modern healthcare facilities that focus on providing same-day surgical care, including diagnostic and preventive procedures, which enhance patient convenience and reduce overall healthcare costs.
The specialized urology clinics segment held a 25% share of the market in 2025 and is expected to grow at a CAGR of 8% between 2026 and 2035. This is mainly due to their strong focus on delivering advanced, targeted treatments for kidney stones and other urological conditions. Some clinics concentrate on general urology, while others specialize in specific subspecialties, enabling more tailored care. The availability of specialized treatment, dedicated infrastructure, and multidisciplinary expert teams focused on urological disorders further supports the growing adoption of these clinics.
Regional Insights
North America Semi-Rigid Ureteroscopy Market Size and Growth 2026 to 2035
The North America flexible and semi-rigid ureteroscopy market size is estimated at USD 525.00 million in 2025 and is projected to reach approximately USD 1,096.95 million by 2035, with a 7.65% CAGR from 2026 to 2035.
North America Led the Flexible and Semi-Rigid Ureteroscopy Market With a 35% Share in 2025
North America registered dominance in the flexible and semi-rigid ureteroscopy market by capturing about 35% share in 2025. This is because of its high healthcare standards, widespread adoption of advanced urology procedures, and the growing prevalence of kidney stones. The region also has one of the highest occurrences of nephrological disorders and is the most established market for ureteroscope usage. Additionally, a well-developed healthcare infrastructure, high patient awareness, and the strong presence of advanced instruments and technologies further support North America's continued dominance in the market.
U.S. Semi-Rigid UreteroscopyMarket Size and Growth 2026 to 2035
The U.S. flexible and semi-rigid ureteroscopy market size is calculated at USD 393.75 million in 2025 and is expected to reach nearly USD 828.20 million in 2035, accelerating at a strong CAGR of 7.72% between 2026 and 2035.
U.S. Market Analysis
The U.S. leads the North American flexible and semi-rigid ureteroscopy market, supported by its advanced healthcare infrastructure and rising procedural volumes. The country has witnessed a significant increase in import shipments of flexible and semi-rigid ureteroscopy equipment. Major companies such as Boston Scientific Corporation, Olympus America, and Stryker Corporation are key contributors to market growth through their strong product portfolios, distribution networks, and ongoing technological innovation.
Asia Pacific: The Fastest-Growing Region
Asia Pacific held a 30% share of the market in 2025 and is expected to grow at the fastest CAGR of 9% in the upcoming period, driven by the need for better diagnostic capabilities and the presence of substantial unmet clinical needs. Rising healthcare expenditure, changing lifestyles, and ongoing industrial development further support market expansion. In addition, favorable import-export dynamics for medical equipment and the gradual strengthening of health insurance frameworks are enhancing access to flexible and semi-rigid ureteroscopy across the region.
China Market Analysis
China is a major player in the Asia Pacific flexible and semi-rigid ureteroscopy market, driven by a rapidly expanding elderly population and rising urological disease burden. Market growth is further supported by strong industrial capabilities and expanding manufacturing infrastructure. Key regional players, including Zhuhai Pusen Medical Technology, Zhuhai Mindhao Medical Technology, and Innovex Medical, are accelerating adoption through local production, product innovation, and broader access to advanced urological equipment.
How is the Opportunistic Rise of Europe in the Flexible and Semi-Rigid Ureteroscopy Market?
Europe held a 25% share of the market in 2025 and is expected to grow at a CAGR of 6.2% during the forecast period, driven by increasing investments in healthcare infrastructure and adoption of advanced diagnostic and therapeutic tools. High health standards, a large elderly population, and well-developed health infrastructure also support regional market growth. High levels of health care with established urology practice throughout Europe have enabled the adoption of new ureteroscopy procedures. The increasing prevalence of kidney stones and existing urological disorders in the European population is a strong driver for ureteroscopes.
Germany Market Analysis
Germany leads the European flexible and semi-rigid ureteroscopy market, supported by a strong regulatory framework that facilitates the timely approval of new products. The country has a high adoption of advanced technologies, including high-definition imaging systems and precision-engineered flexible and rigid ureteroscopes. Key players such as KARL STORZ SE and Co. KG and Richard Wolf GmbH further strengthen the market through continuous innovation, extensive product portfolios, and robust distribution networks.
Flexible and Semi-Rigid Ureteroscopy Market Companies
- Boston Scientific Corporation
- Medtronic PLC
- Cook Medical Inc
- Olympus Corporation
- Karl Storz SE and Co. KG
- Stryker Corporation
- Richard Wolf GmbH
- B. Braun Melsungen AG
- ConMed Corporation
- Teleflex Incorporated
- Inspire Medical Systems, Inc.
- Maxer Endoscopy
- UroVion, Inc.
- Lumenis Ltd.
- Scholten Healthcare Solutions
Recent Developments
- In February 2025, Stryker expanded its urology portfolio with the launch of the F88 flexible ureteroscope, designed to improve access to hard-to-reach anatomy. The device features 270° bidirectional deflection and a graduated flexible insertion tube to reduce stress, along with a high-strength bending section for enhanced durability and performance.(Source: https://www.stryker.com )
- In April 2024, Olympus received U.S. FDA 510(k) clearance for its first single-use ureteroscope system, RenaFlex™. The device is designed to access and visualize the urinary tract for diagnosing and treating conditions like kidney stones, supporting both diagnostic and therapeutic procedures through minimally invasive approaches.(Source: https://www.olympusamerica.com )
Segment Covered in the Report
By Product Type
- Flexible Ureteroscopes
- Semi-Rigid Ureteroscopes
By Application
- Kidney Stones Treatment
- Urinary Tract Infections (UTI) Treatment
- Bladder Tumors Treatment
- Others
By End-Use
- Hospitals
- Specialized Urology Clinics
- Ambulatory Surgery Centers (ASCs)
- Others
By Region
- North America
- Latin America
- Europe
- Asia-pacific
- Middle and East Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Table Of Content
sales@precedenceresearch.com
+1 804-441-9344
Schedule a Meeting